Cytotoxic and antioxidant effects of methoxylated stilbene analogues on HepG2 hepatoma and Chang liver cells: Implications for structure activity relationship

Abstract

Stilbenes possess a variety of biological activities including chemopreventive activity. This study was conducted to evaluate the structural activity relationships of six methoxylated stilbene analogues with respect to their cytotoxic effects and antioxidant activities on HepG2 hepatoma and Chang liver cells. The cytotoxic and total antioxidant activities of six stilbene analogues were determined by MTT and Ferric Reducing Antioxidant Power (FRAP) assays, respectively. We found that the cis-methoxylated stilbene: (Z)-3,4,4'-trimethoxystilbene was the most potent and selective antiproliferative agent (IC₅₀ 89 µM) in HepG2 cells. For the total antioxidant activity, compounds possessing hydroxyl groups at the 4' position namely (E)-3-methoxy-4'-hydroxystilbene, (E)-3,5-dimethoxy-4'-hydroxystilbene (pterostilbene), (E)-4-methoxy-4'-hydroxystilbene showed the highest antioxidant activity. Structure activity relationship studies of these compounds demonstrated that the cytotoxic effect and antioxidant activities of the tested compounds in this study were structurally dependent.

Keywords

cytotoxicity antioxidant HepG2 hepatoma cells Chang liver cells

References

Scalbert A. , Manach C. , Morand C. , Remesy C. , Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45: 287-306.

Roupe KA , Remsberg CM , Yanez JM , Davies NM Pharmacometric of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 2006; 1: 81-101.

Jang M. , Cai L. , Udeani GO , Slowing KV , Thomas CF , Beecher CW Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220.

Aziz HM , Kumar R. , Ahmad N. Cancer chemoprevention by resveratrol In vitro and in vivo studies and underlying mechanisms (Review). Int J Oncol 2003; 23: 17-28.

Aggarwal BB , Bhardwaj A. , Aggarwal RS , Seeram NP , Shishodia S. , Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anti-Cancer Res 2004 ; 24: 2783-2740.

Athar M. , Back JH , Tang X. , Kim KH , Kopelovich L. , Bickers DR , et al. Resveratrol. A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-283.

Kundu JK , Surh YJ Cancer chemoprevention with dietary phytochemicals. Mutat Res 2004; 555: 65-80.

Kundu JK , Surh YJ Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 2008; 269: 243-261.

Inayat-Hussain SH , Thomas NF Recent advances in discovery and development of stilbenes and lactone in anticancer therapy. Expert Opin Ther Pat 2004; 14: 1-17.

10.

Ovesna Z. , Horvathova K. Structure-activity relationship of trans-resveratrol and its analogues (Minireview) . Neoplasma 2005; 52: 450-455.

11.

Mosmann T. Rapid colorimetric assay for cellular growth and survival: Aplication to proliferation and cytotoxicity assays. J Immunol Meth 1983 ; 65: 58-63.

12.

Benzie IFF , Strain JJ The ferric reducing ability of plasma (FRAP) as a measure of ‘‘Antioxidant Power’’: The FRAP assay . Anal Biochem 1996; 239: 70-76.

13.

Roberti M. , Pizzirani D. , Simoni D. , Rondanin R. , Baruchello R. , Bonora C. , et al. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 2003 ; 46: 3546-3554.

14.

Tolomeo M. , Grimaudo S. , Di Cristina A. , Roberti M. , Pizzirani D. , Meli M. , et al. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 2005; 37: 1709-1726.

15.

Firuzi O. , Lacanna A. , Petrucci R. , Marrosu G. , Saso L. Evaluation of the antioxidant activity of flavonoids by ‘‘ferric reducing antioxidant power’’ assay and cyclic voltammetry. Biochim Biophys Acta 2005; 1721: 174-184.

16.

Murias M. , Jager W. , Handler N. , Erker T. , Horvath Z. , Szekeres T. , et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure activity relationship. Biochem Pharmacol 2005; 69: 903-912.

17.

Ashikawa K. , Majumdar S. , Banarjee S. , Bharti AC , Shishoda S. , Aggarwal BB Piceatannol inhibit TNFinduced expression through suppression of IKappa B alpha kinase and p65 phosphorylation. J Immunol 2002; 169: 6490-6497.

18.

Rice-Evans CA , Miller NJ , Panganga G. Structure-antioxidant activity relationships of flavanoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-956.

19.

Spencer JP , Abd-el-Mohsen MM , Rice-Evans CA Cellular uptake and metabolism of flavanoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004; 423: 148-161.

20.

Lima FC , Fernandes-Ferreira M. , Pereira-Wilson C. Phenolic compounds protect HepG2 cells from oxidative damage: relevance of glutathione levels. Life Sci 2006; 79: 2056-2068.

21.

Griffin PS , Bhagooli R. Measuring antioxidant potential in corals using the FRAP assay. J Exper Marine Biol Ecol 2004; 302: 201-211.